Niaid Competing Continuation of Sbir/Sttr Ph Ii Awards
The summary for the Niaid Competing Continuation of Sbir/Sttr Ph Ii Awards grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Niaid Competing Continuation of Sbir/Sttr Ph Ii Awards: This RFA invites applications for the competing continuation of eligible SBIR or STTR Phase II awardees to continue the process of developing a product that requires clinical evaluation and FDA approval. An "eligible application" must develop one of the following products: therapeutics (drugs or antibodies) to treat HIV or HIV-related opportunistic infections, anti- inflammatory therapeutics, improved transplantation strategies, or other new or improved vaccines, antiviral or antimicrobial agents for infectious diseases. The progress from an eligible SBIR/STTR Phase II grant should be commensurate with previous support and indicate the merit of continued NIH research and development (R and D) funding. Activities supported by a competing continuation of a Phase II SBIR/STTR grant may include additional pre-clinical R and D, clinical testing, and other R and D activities needed to meet requirements of the FDA. A competing continuation SBIR/STTR Phase II award may not be used to conduct early stage research (e.g., identifying targets for drugs, initial identification of lead compounds, etc.).
| Federal Grant Title: | Niaid Competing Continuation of Sbir/Sttr Ph Ii Awards |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-AI-04-005 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.85593.856 |
| CFDA Descriptions: | Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Jan 16, 2004 |
| Posted Date: | Nov 03, 2003 |
| Creation Date: | Feb 15, 2004 |
| Archive Date: | Feb 15, 2004 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster